Homepage - value-dx

VALIDATING DIAGNOSTICS

TO COMBAT ANTIMICROBIAL RESISTANCE BY
OPTIMISING ANTIBIOTIC USE

Previous slide

Next slide

ADEQUATE & PRUDENCE

The recruitment face of the ADEQUATE and PRUDENCE trials has successfully reached its targets!

NEWS

VALUE-Dx paper on barriers and facilitators in pricing and funding policies of European countries impacting the use of point-of-care diagnostics for acute respiratory tract infections

Progress and insights from the PRUDENCE and ADEQUATE trials

VALUE-Dx annual meeting recap

CONSORTIUM PARTNERS

SUBSCRIBE TO OUR NEWSLETTER